# A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects

> **NCT02286882** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06409577 or Placebo

## Key facts

- **NCT ID:** NCT02286882
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** The trial was terminated prematurely on June 19, 2015 for business reasons. There were no safety concerns in the study which led to the decision.
- **Last updated:** 2015-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02286882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02286882, "A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02286882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*